Microassay of human erythrocyte catechol-O-methyltransferase: Removal of inhibitory calcium ion with chelating resin

F. A. Raymond, Richard M Weinshilboum

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

A radiochemical micromethod for the determination of catechol-O-methyltransferase (COMT) activity in human red blood cells (RBC) is described. The method avoids artifacts that occur with other assay procedures. Erythrocyte lysates are exposed to a particulate chelating agent (Chelex-100) to remove endogenous divalent cations that inhibit COMT. 3,4-Dihydroxybenzoic acid rather than norepinephrine is used as a substrate to increase both the sensitivity and the reproducibility of the procedure. An internal standard of purified rat liver COMT is added to lysates to detect possible variations in endogenous activators or inhibitors of the enzyme. Blood samples from 373 unselected subjects age 16-18 were assayed for RBC COMT activity with this assay procedure. The COMT activity in these blood samples ranged from 3-25 units with a mean activity of 11.3 ± 4.2 (mean ±S.D.).

Original languageEnglish (US)
Pages (from-to)185-194
Number of pages10
JournalClinica Chimica Acta
Volume58
Issue number2
DOIs
StatePublished - 1975

Fingerprint

Catechol O-Methyltransferase
Chelation
Resins
Erythrocytes
Ions
Calcium
Blood
Assays
Divalent Cations
Enzyme Inhibitors
Chelating Agents
Human Activities
Liver
Artifacts
Rats
Norepinephrine
Cells
Substrates

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Microassay of human erythrocyte catechol-O-methyltransferase : Removal of inhibitory calcium ion with chelating resin. / Raymond, F. A.; Weinshilboum, Richard M.

In: Clinica Chimica Acta, Vol. 58, No. 2, 1975, p. 185-194.

Research output: Contribution to journalArticle

@article{763ed532117d488bb416f93a57ab21e7,
title = "Microassay of human erythrocyte catechol-O-methyltransferase: Removal of inhibitory calcium ion with chelating resin",
abstract = "A radiochemical micromethod for the determination of catechol-O-methyltransferase (COMT) activity in human red blood cells (RBC) is described. The method avoids artifacts that occur with other assay procedures. Erythrocyte lysates are exposed to a particulate chelating agent (Chelex-100) to remove endogenous divalent cations that inhibit COMT. 3,4-Dihydroxybenzoic acid rather than norepinephrine is used as a substrate to increase both the sensitivity and the reproducibility of the procedure. An internal standard of purified rat liver COMT is added to lysates to detect possible variations in endogenous activators or inhibitors of the enzyme. Blood samples from 373 unselected subjects age 16-18 were assayed for RBC COMT activity with this assay procedure. The COMT activity in these blood samples ranged from 3-25 units with a mean activity of 11.3 ± 4.2 (mean ±S.D.).",
author = "Raymond, {F. A.} and Weinshilboum, {Richard M}",
year = "1975",
doi = "10.1016/S0009-8981(75)80012-X",
language = "English (US)",
volume = "58",
pages = "185--194",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Microassay of human erythrocyte catechol-O-methyltransferase

T2 - Removal of inhibitory calcium ion with chelating resin

AU - Raymond, F. A.

AU - Weinshilboum, Richard M

PY - 1975

Y1 - 1975

N2 - A radiochemical micromethod for the determination of catechol-O-methyltransferase (COMT) activity in human red blood cells (RBC) is described. The method avoids artifacts that occur with other assay procedures. Erythrocyte lysates are exposed to a particulate chelating agent (Chelex-100) to remove endogenous divalent cations that inhibit COMT. 3,4-Dihydroxybenzoic acid rather than norepinephrine is used as a substrate to increase both the sensitivity and the reproducibility of the procedure. An internal standard of purified rat liver COMT is added to lysates to detect possible variations in endogenous activators or inhibitors of the enzyme. Blood samples from 373 unselected subjects age 16-18 were assayed for RBC COMT activity with this assay procedure. The COMT activity in these blood samples ranged from 3-25 units with a mean activity of 11.3 ± 4.2 (mean ±S.D.).

AB - A radiochemical micromethod for the determination of catechol-O-methyltransferase (COMT) activity in human red blood cells (RBC) is described. The method avoids artifacts that occur with other assay procedures. Erythrocyte lysates are exposed to a particulate chelating agent (Chelex-100) to remove endogenous divalent cations that inhibit COMT. 3,4-Dihydroxybenzoic acid rather than norepinephrine is used as a substrate to increase both the sensitivity and the reproducibility of the procedure. An internal standard of purified rat liver COMT is added to lysates to detect possible variations in endogenous activators or inhibitors of the enzyme. Blood samples from 373 unselected subjects age 16-18 were assayed for RBC COMT activity with this assay procedure. The COMT activity in these blood samples ranged from 3-25 units with a mean activity of 11.3 ± 4.2 (mean ±S.D.).

UR - http://www.scopus.com/inward/record.url?scp=0016431055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016431055&partnerID=8YFLogxK

U2 - 10.1016/S0009-8981(75)80012-X

DO - 10.1016/S0009-8981(75)80012-X

M3 - Article

C2 - 235384

AN - SCOPUS:0016431055

VL - 58

SP - 185

EP - 194

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 2

ER -